Information, Insurance and Vaccines - Pharmacy Technician Pulse

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

AUGUST 5, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News GSK’s world-first gonorrhoea vaccine launched in England The immunisation programme aims to reduce rising gonorrhoea rates and address antibiotic-resistant strains. GSK’s 4CMenB is not a newly approved vaccine.

Vaccines

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

JUNE 20, 2025

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi. Give your business an edge with our leading industry insights.

Vaccines

Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures

Drug Topics

JULY 1, 2025

They look at the list and they prioritize who they want to take on and who they don't want to take on based on their insurance plan and their drugs. That's dependent upon their insurance plan and the medications they use. Reimbursements are a lot better in vaccines than it is in just filling scripts.

Health and Personal Care Stores

Health and Personal Care Stores Independent Pharmacies Grocery Stores Insurance

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Pharmacy Times

AUGUST 1, 2025

PBMs are more powerful and influential than ever as they become extensions of major health insurers, acquire independent pharmacies, and create new business lines to funnel prescriptions through. Today, the 3 largest PBMs control 80% of the prescription drug market, smothering the competition that is needed to keep oversteps in check.

Specialty Pharmacies Independent Pharmacies Mail-Order Pharmacies Compounding Pharmacies

Pharmacists Bridge the Gaps in Care Transitions

Pharmacy Times

AUGUST 11, 2025

Most MTM platforms use health plan adjudication data, allowing pharmacists to see any medication billed through the patient’s insurance, even if it was not filled at their pharmacy. Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Hospitals

Hospitals Community Pharmacies Specialty Pharmacies Compounding Pharmacies

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

JULY 22, 2025

These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing. Additionally, the role of pharmacy benefit managers (PBMs) cannot be overlooked.

Mail-Order Pharmacies

Mail-Order Pharmacies Community Pharmacies Compounding Pharmacies Immunization

Q&A: How ACIP Changes Could Reshape Patient Care

Drug Topics

JULY 5, 2025

Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Cleveland: So I'll start as a provider.

Patient Care

Patient Care Vaccines Insurance Immunization

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Pharmacy Times

JULY 21, 2025

The most common concerns include the following 1,3-5 : • Cost and insurance barriers: Affordability remains a major barrier, as patients have difficulty accessing CGMs due to high out-of-pocket costs or limited insurance coverage. PLOS Digit Health. 2022;1(10):e0000104. doi:10.1371/journal.pdig.0000104 Subscribe Now!

Compounding Pharmacies Immunization Insurance Coverage Hospitals

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 12, 2025

3 Her program focuses on an appointment-based model and has a cash-based payment model, although they are able to bill some insurances for the visit. 2018.203609 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Am J Public Health.

Independent Pharmacies

Independent Pharmacies Hospitals Compounding Pharmacies Immunization

Turning Reconciliation into a Revenue Growth Engine

Drug Topics

JUNE 23, 2025

Key best practices include maintaining up-to-date insurance information, implementing pre-adjudication edits in dispensing software, and working closely with RCM experts who understand the intricate pharmacy reimbursement landscape.

Patient Care

Patient Care Vaccines Specialty Pharmacies Compounding

Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF

Pharmacy Times

JULY 24, 2025

Christopher Ho, PharmD, BCPS, manager of pharmacy telehealth team at Northwell Health, pointed out that many patients with HFpEF are older and lack commercial insurance, making it harder to access branded therapies. Behind the scenes of TOPCAT – bending to inform. The emerging epidemic of heart failure with preserved ejection fraction.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

JULY 25, 2025

Additional considerations for selection between oral cephalosporin agents include differences in bioavailability and absorption, specific site of infection and the ability of drug to concentrate at that site, local resistance patterns, insurance coverage, available formulations, and cost to the patient. Arthritis Care Res ( Hoboken ).

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Department of Veterans Affairs Immunization Compounding Pharmacies

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Pharmacy Times

JULY 4, 2025

1 For these reasons, the authors conducted this study to evaluate the clinical success and patient outcomes following the mandatory conversion from Humira to a biosimilar because of insurance-related restrictions. Hyrimoz — adalimumab-adaz. Accessed June 26, 2025. Subscribe Now!

Specialty Pharmacies Hospitals Compounding Pharmacies Vaccines

HHS Adopts ACIP Recommendation to Eliminate Thimerosal From Flu Shots

Drug Topics

JULY 24, 2025

Kennedy Jr signed to adopt the CDC's Advisory Committee on Immunization Practices (ACIP) recommendations to remove mercury-based thimerosal from all influenza vaccines distributed in the United States. Kennedy, Jr, endorses ACIP's decision to eliminate thimerosal from US influenza vaccines, prioritizing public health and safety.

Specialty Pharmacies Vaccines Independent Pharmacies Insurance

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Pharmacy Times

JULY 1, 2025

Because] insurance and cost barriers can be difficult for patients, pharmacists can help patients navigate copayment programs and the prior authorization process.” In addition to efficacy and safety, the investigators aim to provide valuable information on functional capacity and survival in this open-label extension. Subscribe Now!

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals

Semaglutide and Tirzepatide Lead the Way in Comprehensive Diabetes and Obesity Management

Pharmacy Times

JULY 23, 2025

Pharmacists are pivotal in patient counseling, therapy selection, and navigating insurance challenges, ensuring comprehensive diabetes management. She also noted the insurance considerations, including involvement with formularies and prior authorization, that come into play when making these decisions.

Insurance

Insurance Compounding Pharmacies FDA Compounding

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

JULY 22, 2025

This change mirrored a January 2025 FDA safety alert and label update that urged providers to consider genetic testing, inform patients of the risks, and discuss available options. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress. Accessed July 21, 2025. link] Roses AD.

Compounding Pharmacies FDA Hospitals Immunization

Pharmacy Policy Updates for June 2025

Pharmacy Times

JUNE 16, 2025

Second, it does not address the core issues of higher prices, such as the use of rebates by insurers. Because Ned Said: New Technology Helps Prevent Opioid Overdose Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Compounding Pharmacies Immunization Hospitals Compounding

Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice

Pharmacy Times

JULY 28, 2025

Treatment selection is influenced by insurance, cost, and patient-specific factors due to the lack of direct RCT comparisons. 7 Based on a lack of head-to-head randomized clinical trials (RCTs), selection of the most appropriate VMAT2 inhibitor is routinely related to insurance approval, affordability, and patient-specific characteristics.

Compounding Pharmacies Compounding Insurance Immunization

Building Intelligent Pharma Supply Chain Management with Real-World Data

Pharmaceutical Commerce

JUNE 17, 2025

Drug tracking data, purchasing information, and usage trends can all be meaningfully applied to build models that generate actionable insights that enhance efficiency, ensure that therapies are available when and where they are needed, enable smarter inventory control, and improve predictive analytics.

Health and Personal Care Stores

Health and Personal Care Stores Hospitals Inventory Control Controlled Substances

‘Pharmacists Are the Care Coordinator,’ in Type 1 Diabetes, Expert Says

Pharmacy Times

AUGUST 12, 2025

And we also manage drug–drug interactions, verify vaccines are up to date, educate care teams on premedications to prevent infusion-related reactions. We connect patients with [teplizumab] compass navigators to help with insurance approvals in a copay program, logistics, and patient education. You can find that online. Subscribe Now!

Specialty Pharmacies Compounding Pharmacies Immunization Compounding

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Chemotherapy

Chemotherapy Packaging Communication Hospitals

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Pharmacy Times

JUNE 17, 2025

That means that pharmacists in the twilight of their career have, at some point, filled a prescription, engaged in drug utilization review, filed insurance claims, and counseled per the Omnibus Budget Reconciliation Act of 1990 regulations for many of the products now found in front of the counter. Am J Health Syst Pharm. 2024;81(14):583-598.

Compounding Pharmacies Drug Utilization Review Immunization Hospitals

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Pharmacy Times

JUNE 23, 2025

Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage. But I also think everyone should have a ready-to-use cover on their insurance. Subscribe Now!

Compounding Pharmacies Insurance Immunization Insurance Coverage

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

Pharmacy Times

JULY 3, 2025

Getting this passed would mean broadening coverage within CMS, and then, hopefully, private insurers would follow suit. CMS leads the way when it comes to new therapies and approval, so hopefully, this means broadening access to both private and government-based insurers. Subscribe Now!

Compounding Pharmacies FDA Immunization Packaging

Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies

Pharmacy Times

JULY 1, 2025

Pharmacy Times: How do you approach dose adjustments or discontinuation of rilonacept therapy, and what information or insights from the pharmacist team are valuable in making these decisions? Sean Krohn : We sometimes receive inquiries from patients, as well as some health care providers, about when patients can stop rilonacept.

Specialty Pharmacies Insurance Compounding Pharmacies Hospitals

How long does it take to become a pharmacist?

SingleCare

MARCH 3, 2022

They might think of a pharmacist counting pills all day and dealing with insurance companies. Multitasking You may have to handle different tasks throughout the day, including educating patients, speaking with healthcare providers, running patient screenings or vaccinations , and taking care of insurance problems.

Hospitals

Hospitals Compounding Communication Insurance

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Pharmaceutical Technology

JUNE 27, 2025

For more information relating to our privacy practices, we invite you to review our privacy policy. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!

Communication Packaging Hospitals Vaccines

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Labelling

Labelling FDA Packaging Communication

Ethris and Thermo Fisher partner on mRNA solutions

Pharmaceutical Technology

JUNE 16, 2025

mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. By partnering with Ethris, we are expanding our services to include cutting-edge mRNA manufacturing, empowering our customers to bring life-changing treatments to patients faster and more efficiently.” You will receive an email shortly.

Vaccines

Russell Springs Pharmacy: A Pharmacy That Feels Like Home

Pharmacy Times

JULY 24, 2025

Someone ended up donating a car, and they used the money to buy tires and insurance. Bridging Gaps in Pharmacy Access Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. The patient was moving away and did not have a car. Subscribe Now!

Independent Pharmacies

Independent Pharmacies Compounding Pharmacies Grocery Stores Immunization

Piramal Pharma announces $90m investment to expand US sites

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Communication Packaging Hospitals Insurance

MAXONA Pharma seeks FDA approval for pain relief MAX-001

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News MAXONA Pharma seeks FDA approval for pain relief MAX-001 MAX-001 provides both rapid onset and extended duration of analgesia. Give your business an edge with our leading industry insights.

FDA

FDA Packaging Compounding Communication

EpiPen patent expiry opens new era for innovation

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News EpiPen patent expiry opens new era for innovation The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in the epinephrine delivery space.

Packaging

Packaging Communication Hospitals Insurance

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Packaging

Packaging Communication Hospitals Pharmaceutical Companies

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Packaging

Packaging Communication Hospitals Insurance

Madrigal poised to enter European MASH market after CHMP endorsement

Pharmaceutical Technology

JUNE 20, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Communication Hospitals Packaging Insurance

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Packaging

Packaging Chemotherapy Communication Hospitals

Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition

Pharmaceutical Technology

AUGUST 4, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition The generics specialist will acquire Just – Evotec Biologics’ biosimilar development and manufacturing plant for $300m.